Literature DB >> 15147715

Myeloid cells.

Hiroshi Kawamoto1, Nagahiro Minato.   

Abstract

Granulocytes and monocytes, collectively called myeloid cells, are differentiated descendants from common progenitors derived from hematopoietic stem cells in the bone marrow. Commitment to either lineage of myeloid cells is controlled by distinct transcription factors followed by terminal differentiation in response to specific colony-stimulating factors and release into the circulation. Upon pathogen invasion, myeloid cells are rapidly recruited into local tissues via various chemokine receptors, where they are activated for phagocytosis as well as secretion of inflammatory cytokines, thereby playing major roles in innate immunity. Genetic alterations in myeloid cells may cause an abnormal increase in mature myeloid or blast cells resulting in chronic or acute myelogenous leukemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147715     DOI: 10.1016/j.biocel.2004.01.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  20 in total

Review 1.  Immune cells and non-immune cells with immune function in mammalian cochleae.

Authors:  Bo Hua Hu; Celia Zhang; Mitchell D Frye
Journal:  Hear Res       Date:  2017-12-20       Impact factor: 3.208

Review 2.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 3.  Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve.

Authors:  Noelle Jurcak; Lei Zheng
Journal:  Pharmacol Ther       Date:  2019-04-29       Impact factor: 12.310

Review 4.  Formation and role of exosomes in cancer.

Authors:  Lindsey T Brinton; Hillary S Sloane; Mark Kester; Kimberly A Kelly
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

Review 5.  Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines.

Authors:  Hannah S Newton; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2022-04-09       Impact factor: 17.873

6.  TRAF3: a novel tumor suppressor gene in macrophages.

Authors:  Almin I Lalani; Chang Luo; Yeming Han; Ping Xie
Journal:  Macrophage (Houst)       Date:  2015-09-30

Review 7.  Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy.

Authors:  Haseeb Zubair; Mohammad Aslam Khan; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Semin Cancer Biol       Date:  2020-05-26       Impact factor: 15.707

8.  Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.

Authors:  Shuangnian Xu; Xi Li; Jianmin Zhang; Jieping Chen
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 9.  Myeloid-derived microRNAs, miR-223, miR27a, and miR-652, are dominant players in myeloid regulation.

Authors:  Anna B Gilicze; Zoltán Wiener; Sára Tóth; Edit Buzás; Éva Pállinger; Franco H Falcone; András Falus
Journal:  Biomed Res Int       Date:  2014-08-11       Impact factor: 3.411

10.  Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.

Authors:  Annika Sommer; Tanja Fadler; Eva Dorfmeister; Anna-Carin Hoffmann; Wei Xiang; Beate Winner; Iryna Prots
Journal:  J Neuroinflammation       Date:  2016-06-30       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.